Paper Chase is a research database designed to offer abstracts of research articles published in journals that have a highly rated impact factor as determined by ISI Impact Factor and PageRank. Abstracts are organized by date, with the most recently published papers listed first. 

Paper Chase

81.

Improving medication safety.

Lancet.
Schnipper JL, Rothschild JM.
| Apr 7, 2012
82.

Survival of children with burn injuries.

Lancet.
Tompkins RG.
| Mar 17, 2012
83.

Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): a randomised, open-label, multicentre, phase 3 trial.

Lancet.
Baselga J, Bradbury I, Eidtmann H, Di Cosimo S, de Azambuja E, Aura C, Gómez H, Dinh P, Fauria K, Van Dooren V, Aktan G, Goldhirsch A, Chang TW, Horváth Z, Coccia-Portugal M, Domont J, Tseng LM, Kunz G, Sohn JH, Semiglazov V, Lerzo G, Palacova M, Probachai V, Pusztai L, Untch M, Gelber RD, Piccart-Gebhart M, Lerzo G.
| Feb 18, 2012
85.

Bioartificial tissues and organs: are we ready to translate?

Lancet.
Ott HC, Mathisen DJ.
| Dec 10, 2011
86.

Statins and safety: can we finally be reassured?

Lancet.
Kohli P, Cannon CP.
| Dec 10, 2011
87.

Denosumab and bone-metastasis-free survival in men with castration-resistant prostate cancer: results of a phase 3, randomised, placebo-controlled trial.

Lancet.
Smith MR, Saad F, Coleman R, Shore N, Fizazi K, Tombal B, Miller K, Sieber P, Karsh L, Damião R, Tammela TL, Egerdie B, Van Poppel H, Chin J, Morote J, Gómez-Veiga F, Borkowski T, Ye Z, Kupic A, Dansey R, Goessl C.
| Jan 7, 2012
88.

Medical complications associated with earthquakes.

Lancet.
Bartels SA, VanRooyen MJ.
| Feb 25, 2012
89.

Aspirin and colorectal cancer prevention in Lynch syndrome.

Lancet.
Chan AT, Lippman SM.
| Dec 17, 2011
90.

Time for zero deaths from tuberculosis.

Lancet.
Keshavjee S, Harrington M, Gonsalves G, Chesire L, Farmer PE.
| Oct 22, 2011
91.

A global scope for global health--including mental health.

Lancet.
Raviola G, Becker AE, Farmer P.
| Nov 5, 2011
93.

Folate and cardiovascular disease: one size does not fit all.

Lancet.
Rimm EB, Stampfer MJ.
| Aug 13, 2011
95.

Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial.

Lancet.
Orban T, Bundy B, Becker DJ, DiMeglio LA, Gitelman SE, Goland R, Gottlieb PA, Greenbaum CJ, Marks JB, Monzavi R, Moran A, Raskin P, Rodriguez H, Russell WE, Schatz D, Wherrett D, Wilson DM, Krischer JP, Skyler JS, Skyler JS.
| Jul 30, 2011
96.

Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trial.

Lancet.
Sherry N, Hagopian W, Ludvigsson J, Jain SM, Wahlen J, Ferry RJ, Bode B, Aronoff S, Holland C, Carlin D, King KL, Wilder RL, Pillemer S, Bonvini E, Johnson S, Stein KE, Koenig S, Herold KC, Daifotis AG, Lenhard J.
| Aug 6, 2011
97.

Myxoma, dyspnoea, tinnitus, scoliosis, and alopecia.

Lancet.
Rajab TK, Shekar P, Falk RH.
| Apr 16, 2011
98.

Social accountability in health professionals' training.

Lancet.
Wen LS, Greysen SR, Keszthelyi D, Bracero J, de Roos PD.
| Dec 3, 2011